The store will not work correctly when cookies are disabled.
3-(4-(4-chlorobenzyloxy)phenylimino)tetrahydro-[1,3,4]thiadiazolo[3,4-a]pyridazine-1(3H)-thione
ID: ALA2268927
PubChem CID: 76330434
Max Phase: Preclinical
Molecular Formula: C19H18ClN3OS2
Molecular Weight: 403.96
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: S=c1s/c(=N\c2ccc(OCc3ccc(Cl)cc3)cc2)n2n1CCCC2
Standard InChI: InChI=1S/C19H18ClN3OS2/c20-15-5-3-14(4-6-15)13-24-17-9-7-16(8-10-17)21-18-22-11-1-2-12-23(22)19(25)26-18/h3-10H,1-2,11-13H2/b21-18-
Standard InChI Key: JYSBLYQJTYLHGK-UZYVYHOESA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
29.6129 -4.1272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6129 -4.9444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3181 -5.3489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3181 -3.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0234 -4.1272 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.0234 -4.9454 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.8015 -5.1983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2826 -4.5364 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.8016 -3.8745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0542 -3.0973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0540 -5.9756 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.8535 -2.9274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4003 -3.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1990 -3.3706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4522 -2.5928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9007 -1.9841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1040 -2.1566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2513 -2.4218 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.7989 -3.0284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5981 -2.8575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1420 -3.4669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9404 -3.2965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1926 -2.5182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6402 -1.9103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8438 -2.0839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9915 -2.3462 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 1 0
3 6 1 0
5 4 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 2 0
7 11 2 0
10 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
15 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 403.96 | Molecular Weight (Monoisotopic): 403.0580 | AlogP: 5.34 | #Rotatable Bonds: 4 |
Polar Surface Area: 31.45 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 6.19 | CX LogP: 5.88 | CX LogD: 5.85 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.55 | Np Likeness Score: -1.26 |
References
1. IHARA T, IIDA T, TAKASUKA S, KOHNO H, SATO Y, NICOLAUS B, BOGER P, WAKABAYASHI K. (1995) Peroxidizing Phytotoxic Activity of 1, 3, 4-Thiadiazolidine-2-thiones and 1, 2, 4-Triazolidine-3, 5-dithiones, 20 (1): [10.1584/jpestics.20.41] |